Our aim is to understanding how our adaptive immune cells, commonly called T and B cells, see and respond to allergens from our environment.

Our goal is to find novel disease mechanisms and molecular targets, that can be used for innovative therapies for inflammatory skin diseases and cutaneous T cell lymphoma.

Make a difference: Become part of the Biobank of skin and blood samples - a new research programme with samples from 3,000 patients who suffer from psoriasis and eczema.

Our aim of CIIR is to investigate the mechanisms by which intestinal fibroblasts regulate intestinal immune function in health and disease.

Our aim is to characterize and understand novel pathways and molecules in T cell activation and differentiation in inflammatory skin diseases.

Our aim in the group is to uncover novel molecular mechanisms that
regulate inflammation and innate immune responses.

The Eidsmo Laboratory explores mechanisms that steer health and immunopathology in human skin.